![]() |
|
|
1 Department of Pharmacology and Toxicology, University of Wisconsin, Madison, Wisconsin.
2 Department of Pharmacology, College of Medicine, State University of Iowa, Iowa City, Iowa
3 Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan
The subcutaneous administration of labeled morphine prior to nonlabeled nalorphine resulted in a significant increase in the CNS levels of morphine in nontolerant dogs. Simultaneous injection of both drugs, or pretreatment with nalorphine resulted in an increase or no change in the CNS levels of morphine in nontolerant dogs as compared with the morphine control dog values.
The effect of nalorphine on the plasma and cerebrospinal fluid concentrations of free morphine was somewhat variable.
Paper chromatographic studies provided no evidence for the presence of an N-C14-methyl labeled metabolite of morphine in the CNS and urinary extracts of nontolerant and tolerant dogs.
Submitted on December 11, 1961
This article has been cited by other articles:
![]() |
L. D. Napier, A. Stanfill, D. A. Yoshishige, K. E. Jackson, B. A. Barron, and J. L. Caffrey Autonomic control of heart rate in dogs treated chronically with morphine Am J Physiol Heart Circ Physiol, December 1, 1998; 275(6): H2199 - H2210. [Abstract] [Full Text] [PDF] |
||||